These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2144209)
1. Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases. Mackay AR; Corbitt RH; Hartzler JL; Thorgeirsson UP Cancer Res; 1990 Sep; 50(18):5997-6001. PubMed ID: 2144209 [TBL] [Abstract][Full Text] [Related]
2. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Liotta LA; Goldfarb RH; Brundage R; Siegal GP; Terranova V; Garbisa S Cancer Res; 1981 Nov; 41(11 Pt 1):4629-36. PubMed ID: 6458354 [TBL] [Abstract][Full Text] [Related]
3. Directed migration of murine and human tumor cells to collagenases and other proteases. Terranova VP; Maslow D; Markus G Cancer Res; 1989 Sep; 49(17):4835-41. PubMed ID: 2547519 [TBL] [Abstract][Full Text] [Related]
4. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Nakajima M; Lotan D; Baig MM; Carralero RM; Wood WR; Hendrix MJ; Lotan R Cancer Res; 1989 Apr; 49(7):1698-706. PubMed ID: 2538232 [TBL] [Abstract][Full Text] [Related]
5. Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junction. Ogura Y; Matsunaga Y; Nishiyama T; Amano S Br J Dermatol; 2008 Jul; 159(1):49-60. PubMed ID: 18460030 [TBL] [Abstract][Full Text] [Related]
6. Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. Hendrix MJ; Wood WR; Seftor EA; Lotan D; Nakajima M; Misiorowski RL; Seftor RE; Stetler-Stevenson WG; Bevacqua SJ; Liotta LA Cancer Res; 1990 Jul; 50(13):4121-30. PubMed ID: 2162253 [TBL] [Abstract][Full Text] [Related]
7. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346 [TBL] [Abstract][Full Text] [Related]
8. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Nakajima M; Welch DR; Belloni PN; Nicolson GL Cancer Res; 1987 Sep; 47(18):4869-76. PubMed ID: 3621180 [TBL] [Abstract][Full Text] [Related]
9. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells. Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081 [TBL] [Abstract][Full Text] [Related]
10. Evidence for a role of the plasminogen activator--plasmin system in corneal ulceration. Berman M; Leary R; Gage J Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1204-21. PubMed ID: 6252112 [TBL] [Abstract][Full Text] [Related]
11. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo. Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317 [TBL] [Abstract][Full Text] [Related]
12. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells. Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475 [TBL] [Abstract][Full Text] [Related]
13. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Reich R; Thompson EW; Iwamoto Y; Martin GR; Deason JR; Fuller GC; Miskin R Cancer Res; 1988 Jun; 48(12):3307-12. PubMed ID: 2836052 [TBL] [Abstract][Full Text] [Related]
14. Contribution of proteases and plasmin-acquired activity in migration of Peptostreptococcus micros through a reconstituted basement membrane. Grenier D; Bouclin R Oral Microbiol Immunol; 2006 Oct; 21(5):319-25. PubMed ID: 16922932 [TBL] [Abstract][Full Text] [Related]
15. Matrix proteins of basement membrane of intrahepatic bile ducts are degraded in congenital hepatic fibrosis and Caroli's disease. Yasoshima M; Sato Y; Furubo S; Kizawa K; Sanzen T; Ozaki S; Harada K; Nakanuma Y J Pathol; 2009 Feb; 217(3):442-51. PubMed ID: 19025978 [TBL] [Abstract][Full Text] [Related]
16. Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells. Maquoi E; Frankenne F; Noël A; Krell HW; Grams F; Foidart JM Exp Cell Res; 2000 Dec; 261(2):348-59. PubMed ID: 11112341 [TBL] [Abstract][Full Text] [Related]
17. Origin of basement membrane type IV collagen in xenografted human epithelial tumor cell lines. Cleutjens JP; Havenith MG; Beek C; Vallinga M; Ten Kate J; Bosman FT Am J Pathol; 1990 May; 136(5):1165-72. PubMed ID: 2349967 [TBL] [Abstract][Full Text] [Related]
18. Distribution of type IV collagen during avian limb bud development. Rayan GM; Abercrombie MP; Linsenmayer TF; Fitch JM; Tomasek JJ J Hand Surg Am; 1999 May; 24(3):619-27. PubMed ID: 10357545 [TBL] [Abstract][Full Text] [Related]
19. Mast cell tryptase and photoaging: possible involvement in the degradation of extra cellular matrix and basement membrane proteins. Iddamalgoda A; Le QT; Ito K; Tanaka K; Kojima H; Kido H Arch Dermatol Res; 2008 Apr; 300 Suppl 1():S69-76. PubMed ID: 17968569 [TBL] [Abstract][Full Text] [Related]
20. Degradation of glycoprotein and collagenous components of the basement membrane: studies with urokinase-type plasminogen activator, alpha-thrombin, and plasmin. Goldfarb RH; Murano G; Brundage R; Siegal GP; Terranova V; Garbisa S; Liotta LA Semin Thromb Hemost; 1986 Oct; 12(4):335-6. PubMed ID: 2947330 [No Abstract] [Full Text] [Related] [Next] [New Search]